Earlier signal.
One model. Every system.
Three surfaces, one substrate.
Critical care decision support that surfaces deterioration trajectories hours before isolated alarms.
Outpatient teams see every patient as one connected system across vitals, labs, and treatments.
Hospital research groups get a FAIR-aligned, audit-ready data substrate for retrospective and prospective work.
Hospital feasibility study.
Hale-X is currently in retrospective feasibility study with a hospital partner, evaluating Anali-X across multimodal ICU streams. The study is designed to characterize lead-time, signal stability, and clinical usability prior to a prospective pilot.
How we connect to your hospital.
FHIR, HL7, and proprietary adapters into the Hale-X substrate, then back out into the surfaces your teams already use.
Built for the EU bar.
Anali-X is in development under the EU Medical Device Regulation framework as a Class IIb clinical decision support tool. Our quality system targets ISO 13485 certification. Hemalyse for Clinics is classified as Class I informational software.
EU-sovereign by default.
Luxembourg, Frankfurt, and Dublin AWS regions. Data never leaves the EU. SLAs negotiable per pilot. Data processing agreements (Article 28) ready on request.